IDiyas

For the Inventor, By the Inventor

Brisbane, CA, United States of America

Yasumichi Hitoshi

USPTO Granted Patents = 20 

 

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 122(Granted Patents)


Location History:

  • Mountain View, CA (US) (2006 - 2011)
  • Brisbane, CA (US) (2013 - 2021)

Company Filing History:

goldMedal20 out of 488 
 
Rigel Pharmaceuticals, Incorporated
 patents

Years Active: 2006-2021

Loading Chart...
Loading Chart...
Loading Chart...
20 patents (USPTO):
1. 11174246 - Direct AMPK activators (2021-11-16),
2. 10941134 - AMPK-activating heterocyclic compounds and methods for using the same (2021-03-09),
3. 10377742 - AMPK-activating heterocyclic compounds and methods for using the same (2019-08-13),
4. 9511058 - Methods for using carboxamide, sulfonamide and amine compounds (2016-12-06),
5. 9383362 - Whole blood assay for measuring AMPK activation (2016-07-05),
6. 9266856 - AMPK—activating heterocyclic compounds and methods for using the same (2016-02-23),
7. 9005909 - Whole blood assay for measuring AMPK activation (2015-04-14),
8. 8987303 - AMPK-activating heterocyclic compounds and methods for using the same (2015-03-24),
9. 8980921 - AMPK-activating heterocyclic compounds and methods for using the same (2015-03-17),
10. 8809370 - AMPK-activating heterocyclic compounds and methods for using the same (2014-08-19),
11. 8796254 - Methods for using carboxamide, sulfonamide and amine compounds (2014-08-05),
12. 8791136 - Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using the same (2014-07-29),
13. 8546433 - Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer (2013-10-01),
14. 7863222 - shRNA library (2011-01-04),
15. 7482130 - NP95: methods of assaying for cell cycle modulators (2009-01-27),

Title: Innovator Spotlight: Yasumichi Hitoshi, Pioneering AMPK-Activating Compounds

Introduction:

Yasumichi Hitoshi, a prolific inventor based in Brisbane, CA, has made significant strides in the field of pharmaceuticals with his groundbreaking work on AMPK-activating compounds. With an impressive portfolio of 20 patents, Hitoshi's contributions to the industry are shaping the landscape of modern medicine.

Latest Patents:

Hitoshi's latest patents showcase his expertise in developing novel AMPK-activating compounds. His inventions include Direct AMPK Activators, which are benzimidazole compounds that have shown promising potential in treating diseases by activating the AMPK pathway. Additionally, his work on AMPK-activating heterocyclic compounds offers new avenues for addressing metabolism-related disorders and conditions.

Career Highlights:

Currently affiliated with Rigel Pharmaceuticals, Incorporated, Hitoshi's role in the company's research and development team has been instrumental in driving innovation in pharmaceuticals. His keen insight and dedication to scientific advancement have garnered him recognition as a leading figure in the industry.

Collaborations:

In his pursuit of pioneering discoveries, Hitoshi has collaborated closely with esteemed colleagues such as Donald G Payan and Rajinder Paul Singh. Together, they have fostered a dynamic environment conducive to exploration and innovation, leading to groundbreaking advancements in the field of pharmaceuticals.

Conclusion:

Yasumichi Hitoshi's relentless pursuit of excellence and unwavering commitment to scientific innovation have positioned him as a trailblazer in the realm of AMPK-activating compounds. His impactful contributions not only showcase his ingenuity but also hold immense promise for improving the lives of individuals affected by various diseases and disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…